Meniere Disease

Comprehensive Clinical Guide: Meniere Disease (Endolymphatic Hydrops)

1. Introduction and Clinical Overview

Meniere Disease (MD), historically termed idiopathic endolymphatic hydrops, is a chronic, episodic disorder of the inner ear characterized by a classic triad of symptoms: fluctuating sensorineural hearing loss, episodic vertigo, and tinnitus (often accompanied by aural fullness).

While the exact prevalence varies, it is estimated to affect approximately 200 per 100,000 individuals, typically manifesting between the fourth and sixth decades of life. It is a disorder that significantly impairs quality of life, requiring a multidisciplinary approach involving otolaryngologists, neurologists, and vestibular physical therapists. Unlike transient vestibular neuritis, Meniere Disease is characterized by its recurrent, unpredictable nature, leading to substantial psychosocial morbidity.

2. Etiology and Pathophysiology

The fundamental hallmark of Meniere Disease is endolymphatic hydrops—the pathological distension of the endolymphatic space within the cochlea and vestibular apparatus.

The Mechanism of Hydrops

The inner ear contains two primary fluid compartments: the perilymph (high sodium, low potassium) and the endolymph (high potassium, low sodium). The endolymph is produced by the stria vascularis and is typically resorbed in the endolymphatic sac. In Meniere Disease, the homeostasis of this fluid is disrupted.

• Malabsorption Hypothesis: Obstruction or dysfunction of the endolymphatic sac prevents proper drainage.
• Hypersecretion Hypothesis: An overproduction of endolymph leads to increased pressure.
• The "Blowout" Theory: As pressure increases, the Reissner’s membrane becomes distended. Eventually, micro-tears occur, allowing potassium-rich endolymph to mix with perilymph. This toxic environment depolarizes the vestibular and auditory hair cells, leading to the sudden onset of vertigo and hearing loss.

Key Etiological Factors

3. Clinical Staging and Grading

The American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) provides a standardized classification for reporting outcomes. Staging is primarily based on the four-tone average (0.5, 1, 2, and 3 kHz) of the affected ear.

Note: The stage is determined by the worst audiogram obtained during the 6-month interval prior to treatment.

4. Standard Clinical Presentation

A patient presenting with Meniere Disease typically exhibits the "Classic Triad." However, presentations vary during early versus late disease stages.

• Episodic Vertigo: Attacks are sudden, lasting from 20 minutes to 24 hours. Patients often report severe nausea and vomiting.
• Fluctuating Hearing Loss: Typically affects low frequencies initially. As the disease progresses, the hearing loss becomes permanent and involves higher frequencies.
• Tinnitus: Often described as a low-pitched "roaring" or "ocean-like" sound.
• Aural Fullness: A sensation of pressure or "plugged" ear, which often acts as a prodrome preceding a vertigo attack.

5. Differential Diagnosis

It is imperative to exclude "Meniere-like" symptoms caused by other underlying pathologies.

1. Vestibular Migraine: Often mimics MD but lacks the progressive hearing loss.
2. Labyrinthitis: Usually follows a viral infection and is a singular, self-limiting event.
3. Acoustic Neuroma (Vestibular Schwannoma): Must be ruled out via MRI with contrast. It presents with progressive hearing loss and disequilibrium.
4. Autoimmune Inner Ear Disease (AIED): Rapidly progressive bilateral hearing loss.
5. Superior Canal Dehiscence (SCD): Vertigo induced by sound or pressure (Tullio phenomenon).

6. Diagnostic Testing Protocols

Diagnosis remains primarily clinical, supported by objective testing.

• Audiometry: The gold standard. Demonstrates low-frequency sensorineural hearing loss.
• Electrocochleography (ECoG): Measures the summating potential (SP) to action potential (AP) ratio. An elevated SP/AP ratio (>0.4) is suggestive of hydrops.
• Vestibular Evoked Myogenic Potentials (VEMP): Assesses the function of the saccule and utricle.
• MRI (Internal Auditory Canal): Essential to rule out structural lesions such as schwannomas or demyelinating diseases.
• Video Head Impulse Test (vHIT): Evaluates the vestibulo-ocular reflex (VOR) in high-frequency ranges.

7. Management and Therapeutic Approaches

Lifestyle Modifications

• Low-Sodium Diet: Limiting intake to <2,000 mg/day to reduce systemic fluid retention.
• Diuretics: Thiazide diuretics (e.g., hydrochlorothiazide/triamterene) are first-line to lower endolymphatic pressure.
• Caffeine/Alcohol/Nicotine Restriction: These substances are known vestibular/cochlear stimulants and triggers.

Medical/Interventional Options

• Intratympanic Steroids: Dexamethasone injections through the tympanic membrane to reduce inflammation.
• Intratympanic Gentamicin: An aminoglycoside used for chemical labyrinthectomy in refractory cases (destroys vestibular hair cells to stop vertigo).
• Endolymphatic Sac Decompression: A surgical procedure to relieve pressure in the sac.
• Labyrinthectomy: Reserved for patients with non-functional hearing in the affected ear.

8. Risks, Contraindications, and Prognosis

• Risks of Treatment: Intratympanic injections carry a risk of permanent hearing loss (especially gentamicin). Surgical interventions carry the standard risks of anesthesia, facial nerve injury, and CSF leak.
• Contraindications: Systemic aminoglycosides should be avoided in patients with renal failure. Diuretics are contraindicated in patients with severe electrolyte imbalances or allergies to sulfonamides.
• Long-term Prognosis: MD is a chronic condition. While the frequency of vertigo attacks often decreases over 5–10 years due to progressive vestibular compensation and "burnout" of the vestibular apparatus, the hearing loss is generally irreversible and progressive.

9. Frequently Asked Questions (FAQ)

Q1: Is Meniere Disease fatal?
A: No, Meniere Disease is not fatal, but it is highly debilitating. The primary risks involve falls during vertigo attacks and the psychological impact of chronic illness.

Q2: Can diet really cure Meniere Disease?
A: There is no "cure." However, a low-sodium diet and lifestyle modifications are highly effective at reducing the frequency and severity of attacks in the majority of patients.

Q3: Why does the hearing fluctuate?
A: The hearing fluctuates because the endolymphatic pressure changes. When pressure is high, the cochlear hair cells are physically compressed or biochemically compromised; when pressure drops, function temporarily improves.

Q4: Is Meniere Disease contagious?
A: No, it is not an infectious disease. It is a disorder of inner ear fluid dynamics.

Q5: What is the "Drop Attack" (Tumarkin’s Otolithic Crisis)?
A: This is a rare, severe manifestation where a patient suddenly falls to the ground without loss of consciousness, caused by a mechanical shift in the otolith organs.

Q6: Will I eventually go deaf?
A: While many patients experience significant hearing loss, total deafness is uncommon. Most patients retain some residual hearing, though it may require amplification.

Q7: Can I drive with Meniere Disease?
A: Driving is generally discouraged during active phases of the disease. Patients must be symptom-free for a period determined by their physician and local regulatory laws.

Q8: What is the difference between Meniere Disease and BPPV?
A: BPPV (Benign Paroxysmal Positional Vertigo) is caused by displaced calcium crystals (otoconia) and results in brief, position-dependent vertigo. Meniere is a systemic fluid disorder with longer-lasting, spontaneous vertigo.

Q9: Does stress trigger Meniere attacks?
A: Yes. Stress is a well-documented trigger. High levels of cortisol and adrenaline can affect inner ear microcirculation and exacerbate symptoms.

Q10: Are there any new treatments on the horizon?
A: Research into gene therapy and specialized drug-delivery pumps (micropumps) that deliver medication directly to the inner ear is ongoing and shows promise for future management.

10. Clinical Conclusion

Meniere Disease remains one of the most challenging diagnoses in otolaryngology. The management must be highly individualized, focusing on symptom control, preservation of residual hearing, and psychological support. While the pathophysiology is rooted in endolymphatic hydrops, the clinical presentation requires a holistic approach that addresses the patient's vestibular health, dietary habits, and mental well-being. Clinicians should maintain a high index of suspicion for differential diagnoses and prioritize MRI imaging in all initial presentations to ensure no occult pathology is overlooked.

Disclaimer: This guide is for educational purposes for healthcare professionals and medical students. It does not replace professional clinical judgment or institutional protocols. Always consult current clinical practice guidelines (e.g., AAO-HNS) for the most recent updates on management.